Transplantation, AutologousBone Marrow TransplantationHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationBone MarrowAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaMelphalanCombined Modality TherapyGraft vs Host DiseaseTreatment OutcomeBone Marrow CellsRemission InductionWhole-Body IrradiationCyclophosphamideRecurrenceBone Marrow PurgingSalvage TherapyStem CellsDisease-Free SurvivalLymphoma, Non-HodgkinEtoposideHodgkin DiseaseBusulfanCytarabineGraft SurvivalCarmustineLiver TransplantationHematopoietic Stem CellsHematologic NeoplasmsSurvival RateMyeloablative AgonistsSurvival AnalysisHematopoietic Stem Cell MobilizationTransplantation ChimeraTissue DonorsRetrospective StudiesVincristineThiotepaLeukemiaPrognosisTime FactorsFollow-Up StudiesHistocompatibility TestingKidney TransplantationAnemia, AplasticLeukemia, Myeloid, AcuteDoxorubicinAntigens, CD34Lymphoma, Mantle-CellHistocompatibilityBone and BonesAmyloidosisDexamethasoneGranulocyte Colony-Stimulating FactorBoronic AcidsLymphomaAntineoplastic Agents, AlkylatingPyrazinesImmunosuppressive AgentsLymphoma, FollicularHematopoiesisMyelodysplastic SyndromesTransplantation, IsogeneicMesenchymal Stem Cell TransplantationAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsPrednisoneLeukemia, MyeloidPodophyllotoxinNeoplasm, ResidualCord Blood Stem Cell TransplantationCell TransplantationAutograftsLymphoma, T-Cell, PeripheralIfosfamideThalidomideLeukapheresisPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ImmunologyGraft RejectionAcute DiseaseHeart TransplantationHepatic Veno-Occlusive DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveInduction ChemotherapyCell DifferentiationT-LymphocytesMice, Inbred C57BLBone Marrow DiseasesLung TransplantationLymphoma, Large B-Cell, DiffuseProspective StudiesGraft vs Leukemia EffectFatal OutcomeImmunosuppressionHLA Antigens